Merck & Co., Inc: Hepatitis B trials

The registry lists 18 Hepatitis B studies with Merck & Co., Inc as lead sponsor. 0 are open to participants now and 13 have results posted.

Phase 2 2Phase 3 15Phase 4 1(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• A Hepatitis B Vaccine Challenge Study After Previous Vaxelis® Vaccination (V419-013)CompletedNCT04490499Phase 3Results posted
• Modified Process Hepatitis B Vaccine in Japanese Young Adults (V232-062)CompletedNCT01463683Phase 3Results posted
• A Study of V419 Given Concomitantly With Prevnar 13™ and RotaTeq™ (V419-006)CompletedNCT01340937Phase 3Results posted
• Safety, Tolerability, and Immunogenicity of V419 Given Concomitantly With Prevnar 13™ and RotaTeq™ (V419-005)CompletedNCT01337167Phase 3Results posted
• Hepatitis B Challenge Dose in Adults (V232-059-10)CompletedNCT01251276Phase 3Results posted
• Efficacy of Peginterferon Alfa-2b in Previously Untreated Subjects With Chronic Hepatitis B and D Co-infection (Study P04603)CompletedNCT00686790Phase 3Results posted
• Study of Modified Process Hib/Hep B Vaccine in Infants (V121-019)(COMPLETED)CompletedNCT00441012Phase 3Results posted
• Study of Recombinant Modified Process Hepatitis B Vaccine in Older Adults (V232-059)(COMPLETED)CompletedNCT00440531Phase 3Results posted
• Hepatitis B Vaccine Predialysis/Dialysis Study (V232-060)CompletedNCT00440297Phase 3Results posted
• Immunogenicity and Safety Study of Proquad® and Infanrix® Hexa When Administered Concomitantly (V221-035)CompletedNCT00432042Phase 3Results posted
• A Study of 2 Doses of a Hepatitis B Vaccine (V232 RECOMBIVAX HB) in Healthy Infants (V232-057)CompletedNCT00414050Phase 3Results posted
• Hepatitis B Vaccine Booster Study (V232-058)(COMPLETED)CompletedNCT00393523Phase 3Results posted
• PegIntron Versus Adefovir in the Treatment of Chronic Hepatitis B (CHB) e Antigen Positive Patients in Taiwan (P04498/MK-4031-278)CompletedNCT00371761Phase 3Results posted
• A Study to Compare Efficacy and Safety of Tenofovir Used Alone or in Combination With Pegylated Interferon Alpha-2b in Participants With Chronic Hepatitis B and Elevated Alanine Aminotransferase (MK-4031-384)WithdrawnNCT01727271Phase 4
• A Research Study to Test Safety, Tolerability, and Immunogenicity of a Recombinant Hepatitis B Vaccine Manufactured With an Upgrade to the Production Process (V232-054)CompletedNCT00489099Phase 3
• Modified Process Hepatitis B Vaccine in Healthy Neonates (V232-056)CompletedNCT00322361Phase 2
• HepeX-B in Post Hepatic Allografts for Treatment of End Stage Liver Disease Due to Hepatitis B InfectionTerminatedNCT00228592Phase 2
• Study of an Investigational Vaccine in Healthy Infants in Taiwan (V441-001)(COMPLETED)CompletedNCT00092469Phase 3